BRETOVAMERAN
UNII RWD33VV79C

Substance Identification & Data

This profile provides standardized clinical and technical data for Bretovameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RWD33VV79C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3026600-00-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RWD33VV79C

CAS Registry Number

3026600-00-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRETOVAMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13560

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bretovameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRETOVAMERAN

Common Names & Synonyms

BRETOVAMERAN [WHO-DD]

RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED PRE-FUSION SPIKE GLYCOPROTEIN OMICRON JN.1 VARIANT (982-PROLINE,983-PROLINE)-SPECIFYING PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER RBP020.32), INNER SALT

Technical Codes

BNT-162B2 OMICRON (JN.1)

External Clinical & Regulatory Resources

Previous UNIIRWC9VY783J

Next UNIIRWD7HZN2FR